Online Program Home
My Program

Keyword Search

Legend:
CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Keyword Search Criteria: multiplicity returned 13 record(s)
Sunday, 07/29/2018
Optimal Multiple Confidence Regions
Edsel Pena, University of South Carolina; Taeho Kim, University of South Carolina
3:05 PM

Monday, 07/30/2018
A Parametric Multiple Comparison Procedure for Clinical Trials with Planned Evaluation of Treatment Effect in Pre-Defined Subgroups and Interim Analyzes
Liang Fang, MyoKardia; Ron Yu, Gilead Sciences, Inc.; Zhishen Ye, Gilead Sciences; Neby Bekele, Gilead Sciences; Ming Lin, Gilead Sciences
3:05 PM

Tuesday, 07/31/2018
Multiple Testing Procedure Consideration in Clinical Trials
Rachael Wen, Sanofi


A Testing Paradigm for Earl Biomedical Research with Many Correlated Tests
Robert Montgomery; Jonathan D Mahnken, University of Kansas Medical Center


Multiplicity Adjustment for Multiple Endpoints Testing in Overall and Subgroup Populations
Libo Sun, Janssen Pharmaceutical R&D; Grace Liu, Johnson & Johnson; Rui Qin, Janssen Pharmaceutical R&D
9:35 AM

A Testing Paradigm for Earl Biomedical Research with Many Correlated Tests
Robert Montgomery; Jonathan D Mahnken, University of Kansas Medical Center
10:00 AM

Multiple Testing Procedure Consideration in Clinical Trials
Rachael Wen, Sanofi
11:30 AM

Reproducibility in Functional Neuroimaging Studies Through the Lens of Multiplicity
Nicole Lazar, University of Georgia
2:25 PM

Wednesday, 08/01/2018
Multiplicity-Controlled Benefiting Subgroup Identification via Credible Subgroups
Patrick Schnell, Ohio State University; Qi Tang, Sanofi; Peter Müller, University of Texas Austin; Brad Carlin, University of Minnesota
8:35 AM

General Covering Principle: a New Approach to Address Multiplicity in Hypothesis Testing
Huajiang Li, Avanir Pharmaceuticals; Hong Zhou, Arkansas State University
8:50 AM

Multiplicity for a Group Sequential Trial with Biomarker Subpopulations
Jing Zhao, Merck
9:20 AM

Controlling the Family-Wise Type I Error Rate in a Phase II POC Trial of the Merck Pneumococcal Vaccine Program: An Application of the Hochberg Approach
Jianing Li, Merck Research Lab
9:35 AM

Estimating Probability of Simultaneous Success with Multiple Endpoints Using Truncated Multi-Variate Correlated Normal Distribution
Tianshuang Wu, AbbVie; Yihua Gu, AbbVie; Ziqian Geng, AbbVie; Saurabh Mukhopadhyay, AbbVie
10:50 AM